Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular uptake mechanisms for exogenous mitochondria refer to the biological pathways through which cells internalize functional mitochondria from the extracellular environment or neighboring cells. This process is not a single molecular target but a complex set of mechanisms including macropinocytosis, endocytosis, and the formation of tunneling nanotubes (TNTs). In therapeutic contexts, such as mitochondrial transplantation, exogenous mitochondria are delivered to rescue cells with compromised bioenergetics, particularly in tissues affected by ischemia or genetic mitochondrial mutations. While specific proteins like CD38 and Miro1 facilitate this transfer, the overall uptake process is a physiological phenomenon rather than a discrete drug receptor. Research in this area focuses on enhancing these pathways to treat myocardial infarction, stroke, and various neurodegenerative disorders.
The uptake of exogenous mitochondria occurs through multiple pathways including actin-dependent macropinocytosis, tunneling nanotubes (TNTs), and extracellular vesicles, aimed at restoring bioenergetics in recipient cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular uptake mechanisms for exogenous mitochondria.